In summary, we identify HDAC4 as a master regulator of the AKI–CKD transition, acting through coordinated deacetylation and phosphorylation of Foxo3a to repress GPX4, exacerbate lipid peroxidation, and drive ferroptosis. Here, HDAC4 is linked to chronic kidney disease.